** Pot stocks linked to the high-inducing compound
Tetrahydrocannabinol (THC) have surged higher in 2020 when
compared to stocks in the non-psychoactive CBD-related
businesses, advisory firm Viridian Capital Advisors says in a
note
** Viridian says THC stocks, like Curaleaf Holdings
CURA.CD , Green Thumb Industries GTII.CD and Cresco Labs
CL.CD , have recorded a YTD gain of ~20%, while CBD shares, in
stark contrast, is showing a YTD loss of ~35%
** Larger U.S. THC companies have thrived due to increased
revenues, greater profitability and stand to benefit further
from upcoming U.S. election - Viridian urn:newsml:reuters.com:*:nL4N2GZ3JR
** The venture capital fund also notes larger cap THC stocks
have better trading volume and liquidity than CBD counterparts,
attracting investors
** Unlike THC, hemp-derived CBD is federally legal but has
been plagued by excess production, brand proliferation and
pricing declines - Viridian
** CBD, a derivative of the cannabis plant, is believed to
ease anxiety and other ills without the high of its close
cousin, marijuana
** Charlotte's Web Holdings CWEB.TO , Neptune Wellness
Solutions NEPT.TO , CV Sciences CVSI.PK are among the CBD
stocks included in the report
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
HC-linked pot stocks outperform https://tmsnrt.rs/3lE6AKR
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
(Reporting by Shradha Singh in Bengaluru)
((Shradha.Singh@thomsonreuters.com; within U.S. +1 646 223 8780
Ext: 2804, outside U.S. +91 80 6182 2630;))